Publications by authors named "Matthew I Milstein"

Claim this Profile
P
Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations.
Elio Adib, Katarzyna Klonowska, Krinio Giannikou, Khanh T Do, Solida Pruitt-Thompson, Matthew I Milstein

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help.
Marcus O Butler, Osamu Imataki, Yoshihiro Yamashita, Makito Tanaka, Sascha Ansén, Matthew I Milstein

PLoS One· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cells.
Osamu Imataki, Sascha Ansén, Makito Tanaka, Marcus O Butler, Alla Berezovskaya, Matthew I Milstein

J Immunol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells.
Marcus O Butler, Philip Friedlander, Matthew I Milstein, Mary M Mooney, Genita Metzler

Sci Transl Med· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.
Marcus O Butler, Sascha Ansén, Makito Tanaka, Osamu Imataki, Alla Berezovskaya, Matthew I Milstein

Int Immunol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis